Jupiter Neurosciences, Inc. (JUNS)
0.3416
-0.01
(-2.12%)
USD |
NASDAQ |
Mar 27, 11:52
Jupiter Neurosciences Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 59.61M |
| Phio Pharmaceuticals Corp. | 12.40M |
| Jaguar Health, Inc. | 6.259M |
| MetaVia, Inc. | 0.861M |
| Seastar Medical Holding Corp. | 2.311M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.154M |
| Free Cash Flow | -6.742M |
| Free Cash Flow Per Share (Quarterly) | -0.0339 |
| Free Cash Flow to Equity (Quarterly) | -1.151M |
| Free Cash Flow to Firm (Quarterly) | -1.153M |
| Free Cash Flow Yield | -59.16% |